Investigational CAR-T cell therapy

· Hebei Senlang Biotechnology Inc., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Investigational CAR-T cell therapy, covering 2025-06-24 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing